BIOATLA, INC. (BCAB) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $515.30M; Retained Earnings (Accumulated Deficit)USD $-551.54M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $514.68M; Retained Earnings (Accumulated Deficit)USD $-551.99M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $509.46M; Retained Earnings (Accumulated Deficit)USD $-545.65M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $504.62M; Retained Earnings (Accumulated Deficit)USD $-535.86M.
BIOATLA, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $515.30M | $-551.54M | $-36.24M | $-36.24M | 3 month · $619.00K 6 month · $1.57M | (m) | (m) |
| 2026-03-31 | $0.00 | $0.00 | $514.68M | $-551.99M | $-37.31M | $-37.31M | 3 month · $956.00K | (m) | (m) |
| 2025-12-31 | $0.00 | $0.00 | $509.46M | $-545.65M | $-36.19M | $-36.19M | 12 month · $5.43M | (m) | (m) |
| 2025-09-30 | $0.00 | $6.00K | $504.62M | $-535.86M | $-31.24M | $-31.24M | 3 month · $1.29M 9 month · $4.31M | (m) | (m) |
| 2025-06-30 | $0.00 | $6.00K | $503.33M | $-520.08M | $-16.75M | $-16.75M | 3 month · $1.38M 6 month · $3.02M | (m) | (m) |
| 2025-03-31 | $0.00 | $6.00K | $501.91M | $-501.37M | $547.00K | $547.00K | 3 month · $1.65M | (m) | (m) |
| 2024-12-31 | $0.00 | $6.00K | $500.30M | $-486.04M | $14.27M | $14.27M | 12 month · $8.92M | (m) | (m) |
| 2024-09-30 | $0.00 | $5.00K | $494.12M | $-471.15M | $22.97M | $22.97M | 3 month · $2.19M 9 month · $6.99M | (m) | (m) |
| 2024-06-30 | $0.00 | $5.00K | $491.93M | $-460.57M | $31.37M | $31.37M | 3 month · $2.50M 6 month · $4.80M | (m) | (m) |
| 2024-03-31 | $0.00 | $5.00K | $489.21M | $-439.50M | $49.72M | $49.72M | 3 month · $2.30M | (m) | (m) |
| 2023-12-31 | $0.00 | $5.00K | $486.93M | $-416.26M | $70.67M | $70.67M | 12 month · $13.54M | (m) | (m) |
| 2023-09-30 | $0.00 | $5.00K | $484.04M | $-389.34M | $94.70M | $94.70M | 3 month · $3.52M 9 month · $10.81M | (m) | (m) |
| 2023-06-30 | $0.00 | $5.00K | $480.52M | $-356.01M | $124.52M | $124.52M | 3 month · $3.67M 6 month · $7.29M | (m) | (m) |
| 2023-03-31 | (m) | $5.00K | $476.68M | $-320.26M | $156.43M | $156.43M | 3 month · $3.61M | (m) | (m) |
| 2022-12-31 | $0.00 | $5.00K | $473.13M | $-292.80M | $180.34M | $180.34M | 12 month · $14.56M | (m) | (m) |
| 2022-09-30 | $0.00 | $4.00K | $407.89M | $-265.26M | $142.63M | $142.63M | 3 month · $3.59M 9 month · $11.06M | (m) | (m) |
| 2022-06-30 | $0.00 | $4.00K | $404.43M | $-239.48M | $164.95M | $164.95M | 3 month · $3.84M 6 month · $7.47M | (m) | (m) |
| 2022-03-31 | (m) | $4.00K | $400.62M | $-210.57M | $190.05M | $190.05M | 3 month · $3.63M | (m) | (m) |
| 2021-12-31 | $0.00 | $4.00K | $397.14M | $-186.32M | $210.82M | $210.82M | 12 month · $25.12M | (m) | (m) |
| 2021-09-30 | (m) | $4.00K | $393.58M | $-162.93M | $230.65M | $230.65M | 3 month · $4.37M 9 month · $21.31M | (m) | (m) |
| 2021-06-30 | (m) | $3.00K | $318.02M | $-140.00M | $178.02M | $178.02M | 3 month · $12.30M 6 month · $16.94M | (m) | (m) |
| 2021-03-31 | (m) | $3.00K | $305.53M | $-109.62M | $195.92M | $195.92M | 3 month · $4.64M | (m) | (m) |
| 2020-12-31 | $0.00 | $3.00K | $300.89M | $-90.92M | $209.97M | $209.97M | 12 month · $3.02M | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-74.52M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-63.84M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-57.62M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $-56.01M | $-56.01M | (m) | 12 month · $534.00K | 12 month · $764.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-28.45M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |